Unadjusted hazard ratio (HR) and 95% CI for developing cardiovascular diseases among breast cancer (BC) patients compared to controls
Condition . | Unadjusted HR [95% CI] BC patients vs. controls . |
---|---|
Ischaemic heart disease | 1.08 [0.97–1.20] |
Pulmonary embolism | 3.00 [2.51–3.59] |
Atrial fibrillation | 1.53 [1.38–1.70] |
Other cardiac arrhythmias | 1.43 [1.27–1.61] |
Heart failure | 1.93 [1.33–2.80] |
Peripheral vascular disease | 1.08 [0.86–1.35] |
Hypertensive heart disease | 1.79 [1.67–1.91] |
Heart valve disease | 2.02 [1.79–2.27] |
Condition . | Unadjusted HR [95% CI] BC patients vs. controls . |
---|---|
Ischaemic heart disease | 1.08 [0.97–1.20] |
Pulmonary embolism | 3.00 [2.51–3.59] |
Atrial fibrillation | 1.53 [1.38–1.70] |
Other cardiac arrhythmias | 1.43 [1.27–1.61] |
Heart failure | 1.93 [1.33–2.80] |
Peripheral vascular disease | 1.08 [0.86–1.35] |
Hypertensive heart disease | 1.79 [1.67–1.91] |
Heart valve disease | 2.02 [1.79–2.27] |
Unadjusted hazard ratio (HR) and 95% CI for developing cardiovascular diseases among breast cancer (BC) patients compared to controls
Condition . | Unadjusted HR [95% CI] BC patients vs. controls . |
---|---|
Ischaemic heart disease | 1.08 [0.97–1.20] |
Pulmonary embolism | 3.00 [2.51–3.59] |
Atrial fibrillation | 1.53 [1.38–1.70] |
Other cardiac arrhythmias | 1.43 [1.27–1.61] |
Heart failure | 1.93 [1.33–2.80] |
Peripheral vascular disease | 1.08 [0.86–1.35] |
Hypertensive heart disease | 1.79 [1.67–1.91] |
Heart valve disease | 2.02 [1.79–2.27] |
Condition . | Unadjusted HR [95% CI] BC patients vs. controls . |
---|---|
Ischaemic heart disease | 1.08 [0.97–1.20] |
Pulmonary embolism | 3.00 [2.51–3.59] |
Atrial fibrillation | 1.53 [1.38–1.70] |
Other cardiac arrhythmias | 1.43 [1.27–1.61] |
Heart failure | 1.93 [1.33–2.80] |
Peripheral vascular disease | 1.08 [0.86–1.35] |
Hypertensive heart disease | 1.79 [1.67–1.91] |
Heart valve disease | 2.02 [1.79–2.27] |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.